Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Elutia (Nasdaq: ELUT) will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026.
Rhea-AI Summary
Elutia (Nasdaq: ELUT) will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. Management will host a conference call and webcast at 5:00 p.m. Eastern / 2:00 p.m. Pacific, accessible via online registration and through the Investors section of Elutia’s website.
Positive
- None.
Negative
- None.
Details
Market reaction after 2Q26 earnings date: ELUT -5.33% in the Jul 31 session
In the Jul 31 session, ELUT declined 5.33%, reflecting a notable negative market reaction. Argus tracked a trough of -5.2% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reporting period
- Second quarter 2026
- Financial results announcement
- Results release date
- Thursday, August 13, 2026
- After market close
- Conference call time
- 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time
- August 13, 2026
- Recommended login time
- 10 minutes
- Prior to the scheduled conference call
Previous Earnings date Reports
-
Scheduled first-quarter 2026 results release and management conference call
-
Scheduled fourth-quarter 2025 results release and management conference call
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., July 31, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
Dial-In: Click here
To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Elutia Investor Relations
ir@elutia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.